cancer clinical trials for Thoracic (ONC)

17 Thoracic (ONC) clinical trials found. View a list of all cancer clinical trial types.

• A Phase I/II, Open-Label, Dose-Escalation and Expansion First-In-Human Study of ATX-295, an Oral Inhibitor of the Kinesin Motor Protein KIF18A, in Patients With Locally Advanced or Metastatic Solid Tumors, Including High-Grade Serous Ovarian Cancer

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase II Study of Cabozantinib in Combination With Cemiplimab (Cabo-Cemiplimab) Versus Cabozantinib Alone in Adolescents and Adults With Advanced Adrenocortical Cancer

  Current Status: Open

  View links and contact information related to this clinical trial

• Ivonescimab Combined with Chemotherapy Versus Pembrolizumab Combined with Chemotherapy for the First-line Treatment of Metastatic Squamous Non-small Cell Lung Cancer

  Current Status: Open

  View links and contact information related to this clinical trial

• The ROSE Study - Research On Survivorship Experiences. Disparities in cancer-related outcomes between rural and non-rural cancer survivors in the catchment areas of the Big 10 Cancer Research Consortium's Population Science Working Group

  Current Status: Open

  View links and contact information related to this clinical trial

• A randomized Phase II trial of adjuvant Pembrolizumab versus observation following curative resection for stage I non-small cell lung cancer (NSCLC) with primary tumors between 1-4 cm: Big Ten Cancer Research Consortium BTCRC-LUN18-153

  Current Status: Open

  View links and contact information related to this clinical trial

• Consolidative Use of Radiotherapy to Block (CURB2) Oligoprogression In Patients With Metastatic Non-Small-Cell Lung Cancer

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase I Study of IM-1021 in Participants with Advanced Malignancies

  Current Status: Open

  View links and contact information related to this clinical trial

• An Open-label, Randomized Study of BMS-986489 (Atigotatug + Nivolumab Fixed-dose Combination) vs Durvalumab as Consolidation Therapy Following Chemoradiotherapy in Limited-stage Small-cell Lung Cancer (TIGOS-LS)

  Current Status: Open

  View links and contact information related to this clinical trial

• Targeted Agent and Profiling Utilization Registry (TAPUR) Study

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase I/II Study of Inhaled KB707 in Patients with Advanced Solid Tumor Malignancies Affecting the Lungs

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase III, Multicenter, Randomized, Open-label Study of Ifinatamab Deruxtecan (I-DXd), a B7-H3 Antibody Drug Conjugate (ADC), Versus Treatment of Physician's Choice (TPC) in Subjects With Relapsed Small Cell Lung Cancer (SCLC) (IDeate-Lung02)

  Current Status: Open

  View links and contact information related to this clinical trial

• Establishment of a national biorepository to advance studies of immune-related adverse events

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase II/III, Multicenter, Randomized Open-Label Study of Zanzalintinib vs Everolimus in Participants With Previously Treated, Unresectable, Locally Advanced or Metastatic Neuroendocrine Tumors

  Current Status: Open

  View links and contact information related to this clinical trial

• A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)

  Current Status: Open

  View links and contact information related to this clinical trial

• A Randomized Study Evaluating GLIADEL Compared to Stereotactic Radiosurgery in Patients with Metastatic Brain Disease

  Current Status: Open

  View links and contact information related to this clinical trial

• PADL1NK-005: A Randomized, Phase 3, Open-Label Study to Evaluate PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

  Current Status: Open

  View links and contact information related to this clinical trial

• An Observational Study Associating Adiponectin Signaling with Acute and Chronic Toxicity Following Pelvic Radiation

  Current Status: Open

  View links and contact information related to this clinical trial